#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Extra-osseous Ewing's sarcoma recurrent Parkinson's disease Angiosarcoma recurrent Breast cancer metastatic Mucous membrane pemphigoid Penile cancer B-cell small lymphocytic lymphoma recurrent Friedreich's ataxia Osteosarcoma T-cell type acute leukaemia Rectal cancer Small intestine neuroendocrine tumour Waldenstrom's macroglobulinaemia refractory Oesophageal atresia Choroid melanoma More trials…

    Learn about Rare Diseases

    Glycogen storage disease type V Burkitt’s lymphoma – Diagnostics Hepatoblastoma – Treatment Glomerulonephritis membranoproliferative – Treatment Immunodeficiency congenital – Diagnostics Pituitary-dependent Cushing’s syndrome – Treatment Myxofibrosarcoma – Basic Information Progressive supranuclear palsy – Diagnostics Stevens-Johnson syndrome – Trials in Disease Cystic fibrosis lung – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    RNMB2 Lomustine Ampreloxetine Thiopental Sodium Baricitinib Wt1/Il15/Il15Ra Mrna Dc Citicoline Sodium Mepivacaine Hydrochloride Mk-0482 Ptc518 Ontasameran Doxylamine Hydrogen Succinate Dexketoprofen Trometamol Fluorescein Sodium Valemetostat Tosilate Foscarnet Tak-280 Goserelin Retifanlimab Sodium Alginate More therapies…

    Learn about Your Condition

    Sjogren's syndrome Myotonic dystrophy Abortion threatened Non-small cell lung cancer Neonatal respiratory failure Meningorrhagia Vomiting Mantle cell lymphoma stage III Pneumococcal infection Palpitations Small intestine adenocarcinoma Skin wrinkling Juvenile psoriatic arthritis Stevens-Johnson syndrome Breast angiosarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San…

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Vgb Sfnze Sifez 7iq Cfxbhmuj 9gmzah Izcam

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Tafasitamab
    • Betamethasone Sodium Phosphate
    • Cyclophosphamide
    Austria Czechia France Germany Hungary Ireland +5

  • Study on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Itepekimab
    Bulgaria Czechia Denmark Estonia France Germany +12
Previous Page
1 … 29 30 31

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!